Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: Antidrug antibody to achieve systemic drug rescue

R. A. Kroll, M. A. Pagel, J. J. Langone, G. J. Sexton, Edward Neuwelt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The feasibility of utilizing the differential permeability of the blood-tumour barrier to low- vs. high-molecular-weight compounds is demonstrated in a brain tumour model. Nude rats (n = 27) with or without intracerebral tumours received intravenous [3H]methotrexate (M(r) 454), followed 60 min later by antimethotrexate antibody (M(r) 150 000) or nonspecific mouse antibody. Antimethotrexate antibody resulted in 93% binding of serum methotrexate. In contrast, the percentage of antibody-bound methotrexate in brain and intracerebral tumour was only slightly greater than preantibody protein binding. Methotrexate delivery to tumour was significantly greater than to brain adjacent to tumour and normal brain. The percentage delivery of [3H]methotrexate to all areas of brain was similar between animals receiving antimethotrexate antibody and nonspecific antibody. These findings support the theory that a drug rescue method may be developed that may permit the safe administration of increased dosages of chemotherapeutic drugs for the treatment of intracerebral tumours.

Original languageEnglish (US)
Pages (from-to)333-341
Number of pages9
JournalTherapeutic Immunology
Volume1
Issue number6
StatePublished - 1994

Fingerprint

Drug Repositioning
Permeability
Methotrexate
Antibodies
Brain Neoplasms
Neoplasms
Nude Rats
Brain
Protein Binding
Molecular Weight
Serum
Pharmaceutical Preparations

Keywords

  • Blood-brain barrier
  • Brain tumour
  • Chemotherapy
  • Drug rescue
  • Methotrexate
  • Monoclonal antibody

ASJC Scopus subject areas

  • Immunology

Cite this

Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats : Antidrug antibody to achieve systemic drug rescue. / Kroll, R. A.; Pagel, M. A.; Langone, J. J.; Sexton, G. J.; Neuwelt, Edward.

In: Therapeutic Immunology, Vol. 1, No. 6, 1994, p. 333-341.

Research output: Contribution to journalArticle

@article{c6621db6ab144dedb0aafc538e99bc44,
title = "Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: Antidrug antibody to achieve systemic drug rescue",
abstract = "The feasibility of utilizing the differential permeability of the blood-tumour barrier to low- vs. high-molecular-weight compounds is demonstrated in a brain tumour model. Nude rats (n = 27) with or without intracerebral tumours received intravenous [3H]methotrexate (M(r) 454), followed 60 min later by antimethotrexate antibody (M(r) 150 000) or nonspecific mouse antibody. Antimethotrexate antibody resulted in 93{\%} binding of serum methotrexate. In contrast, the percentage of antibody-bound methotrexate in brain and intracerebral tumour was only slightly greater than preantibody protein binding. Methotrexate delivery to tumour was significantly greater than to brain adjacent to tumour and normal brain. The percentage delivery of [3H]methotrexate to all areas of brain was similar between animals receiving antimethotrexate antibody and nonspecific antibody. These findings support the theory that a drug rescue method may be developed that may permit the safe administration of increased dosages of chemotherapeutic drugs for the treatment of intracerebral tumours.",
keywords = "Blood-brain barrier, Brain tumour, Chemotherapy, Drug rescue, Methotrexate, Monoclonal antibody",
author = "Kroll, {R. A.} and Pagel, {M. A.} and Langone, {J. J.} and Sexton, {G. J.} and Edward Neuwelt",
year = "1994",
language = "English (US)",
volume = "1",
pages = "333--341",
journal = "Therapeutic Immunology",
issn = "0967-0149",
number = "6",

}

TY - JOUR

T1 - Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats

T2 - Antidrug antibody to achieve systemic drug rescue

AU - Kroll, R. A.

AU - Pagel, M. A.

AU - Langone, J. J.

AU - Sexton, G. J.

AU - Neuwelt, Edward

PY - 1994

Y1 - 1994

N2 - The feasibility of utilizing the differential permeability of the blood-tumour barrier to low- vs. high-molecular-weight compounds is demonstrated in a brain tumour model. Nude rats (n = 27) with or without intracerebral tumours received intravenous [3H]methotrexate (M(r) 454), followed 60 min later by antimethotrexate antibody (M(r) 150 000) or nonspecific mouse antibody. Antimethotrexate antibody resulted in 93% binding of serum methotrexate. In contrast, the percentage of antibody-bound methotrexate in brain and intracerebral tumour was only slightly greater than preantibody protein binding. Methotrexate delivery to tumour was significantly greater than to brain adjacent to tumour and normal brain. The percentage delivery of [3H]methotrexate to all areas of brain was similar between animals receiving antimethotrexate antibody and nonspecific antibody. These findings support the theory that a drug rescue method may be developed that may permit the safe administration of increased dosages of chemotherapeutic drugs for the treatment of intracerebral tumours.

AB - The feasibility of utilizing the differential permeability of the blood-tumour barrier to low- vs. high-molecular-weight compounds is demonstrated in a brain tumour model. Nude rats (n = 27) with or without intracerebral tumours received intravenous [3H]methotrexate (M(r) 454), followed 60 min later by antimethotrexate antibody (M(r) 150 000) or nonspecific mouse antibody. Antimethotrexate antibody resulted in 93% binding of serum methotrexate. In contrast, the percentage of antibody-bound methotrexate in brain and intracerebral tumour was only slightly greater than preantibody protein binding. Methotrexate delivery to tumour was significantly greater than to brain adjacent to tumour and normal brain. The percentage delivery of [3H]methotrexate to all areas of brain was similar between animals receiving antimethotrexate antibody and nonspecific antibody. These findings support the theory that a drug rescue method may be developed that may permit the safe administration of increased dosages of chemotherapeutic drugs for the treatment of intracerebral tumours.

KW - Blood-brain barrier

KW - Brain tumour

KW - Chemotherapy

KW - Drug rescue

KW - Methotrexate

KW - Monoclonal antibody

UR - http://www.scopus.com/inward/record.url?scp=0028568512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028568512&partnerID=8YFLogxK

M3 - Article

C2 - 7584509

AN - SCOPUS:0028568512

VL - 1

SP - 333

EP - 341

JO - Therapeutic Immunology

JF - Therapeutic Immunology

SN - 0967-0149

IS - 6

ER -